Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 USD | -2.99% |
|
-7.05% | -15.77% |
18/06 | Abeona Therapeutics Files for $300 Million Mixed Shelf, $75 Million At-The-Market Offering | MT |
30/05 | Stifel Starts Abeona Therapeutics With Buy Rating, $21 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.77% | 17Cr | |
+38.36% | 5.27TCr | |
+39.21% | 3.9TCr | |
-8.63% | 3.85TCr | |
+25.46% | 3.04TCr | |
-11.17% | 2.64TCr | |
+11.44% | 2.61TCr | |
+45.09% | 1.42TCr | |
+32.93% | 1.26TCr | |
-5.30% | 1.15TCr |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Abeona Therapeutics Shares Slump After Plans to Reapply for Pz-cel Drug Approval